2021
DOI: 10.1002/chem.202104451
|View full text |Cite
|
Sign up to set email alerts
|

Carrier Protein‐Free Enzymatic Biaryl Coupling in Arylomycin A2 Assembly and Structure of the Cytochrome P450 AryC

Abstract: What is the most significant result of this study?Many potent glycopeptide antibiotics, such as vancomycin, contain biaryl structural features. These are biosynthetically introduced by dedicated cytochrome P450 enzymes, which require their substrate to be bound to a carrier protein as a precondition for substrate recognition. AryC, by contrast, accepts free, untethered substrates to install the biaryl bond in arylomycin antibiotics. It is thus a unique enzyme for biaryl peptide construction with huge potential… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 0 publications
0
14
0
Order By: Relevance
“…A cytochrome P450 protein (AryC) was recently conrmed to generate the biaryl bond, in a process that occurs aer cleavage of the peptide from the NRPS. 142 2.1.15 K97-0239s and enamidonin. K97-0239A and K97-0239B are cyclic lipopeptides isolated from Streptomyces sp.…”
Section: Reviewmentioning
confidence: 99%
See 1 more Smart Citation
“…A cytochrome P450 protein (AryC) was recently conrmed to generate the biaryl bond, in a process that occurs aer cleavage of the peptide from the NRPS. 142 2.1.15 K97-0239s and enamidonin. K97-0239A and K97-0239B are cyclic lipopeptides isolated from Streptomyces sp.…”
Section: Reviewmentioning
confidence: 99%
“…A cytochrome P450 protein (AryC) was recently confirmed to generate the biaryl bond, in a process that occurs after cleavage of the peptide from the NRPS. 142…”
Section: Identification and Biosynthesis Of Lipopeptides From Strepto...mentioning
confidence: 99%
“…It was recently discovered that the enzyme AryC accomplishes a similar intramolecular C−C coupling reaction using only a lipophilic chain instead of a PCP tether to anchor the substrate within the enzyme active site. 368 Recently, a P450 from Streptomyces sp. MG-AR, originally identified for its ability to hydroxylate testosterone, was engineered to enable gram-scale oxidative coupling of the arylomycin core, demonstrating scalable production of this medicinally relevant motif (Scheme 55A).…”
Section: C−c Bond Forming Reactionsmentioning
confidence: 99%
“…16 Alternatively, P450s exert control over the bond formation step following the initial oxidation, providing a platform for site-and atroposelective biaryl coupling reactions. 17 Although a number of these P450s are carrier protein-dependent 18 or limited to intramolecular biaryl bond forming events (such as in the formation of 3), 19 a growing number of P450s have been identified to perform intermolecular oxidative biaryl coupling reactions. 13,20 Despite the prevalence of biaryl natural products in all kingdoms of life, to date, the only P450s that have been discovered to catalyze intermolecular biaryl coupling reactions are from microbial sources.…”
mentioning
confidence: 99%
“…Alternatively, P450s exert control over the bond formation step following the initial oxidation, providing a platform for site- and atroposelective biaryl coupling reactions . Although a number of these P450s are carrier protein-dependent or limited to intramolecular biaryl bond forming events (such as in the formation of 3 ), a growing number of P450s have been identified to perform intermolecular oxidative biaryl coupling reactions. , Despite the prevalence of biaryl natural products in all kingdoms of life, to date, the only P450s that have been discovered to catalyze intermolecular biaryl coupling reactions are from microbial sources . Among these, fungal P450s have demonstrated particularly impressive control over the site- and atroposelective formation of biaryl metabolites. , However, the membrane-bound nature and catalytic-dependence on a separate reductase enzyme has limited the use of fungal P450s as biocatalysts in organic synthesis …”
mentioning
confidence: 99%